AMR Industry Alliance Formed To Ensure Pharma Involvement In Addressing Antimicrobial Resistance

CIDRAP News: Pharma leaders announce alliance to fight antimicrobial resistance
“An international association of pharmaceutical, biotechnology, and diagnostics companies [Thursday] announced the formation of a new alliance to monitor and drive industry efforts to fight antimicrobial resistance (AMR). The AMR Industry Alliance aims to bring together stakeholders from the life sciences industry to ensure progress is made on their commitments to reduce the development of antimicrobial resistance, invest in research and development, and improve global access to antimicrobials, diagnostic tests, and vaccines…” (Dall, 5/18).

Devex: New drug industry alliance will tackle antibiotic resistance
“…The initiative is being launched on the back of recent commitments, including the Industry Declaration on AMR and subsequent Roadmap, which were signed by more than 100 companies and trade associations during meetings at last year’s World Economic Forum and a high-level United Nations meeting on AMR. The commitments set out a plan for global action to reduce AMR through investing in research and development, [and] improving access to antibiotics, vaccines, and diagnostics…” (Edwards, 5/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.